ketanserin has been researched along with Recrudescence in 5 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Accordingly, coronary thrombosis was induced in anesthetized, open-chest dogs by insertion of a copper coil into the left anterior descending coronary artery (LAD)." | 5.27 | Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis. ( Ashton, JH; Buja, LM; Glas-Greenwalt, P; Golino, P; McNatt, J; Willerson, JT, 1988) |
| "Ketanserin is a serotonin S2-receptor antagonist that inhibits the platelet activation and vasoconstriction induced by serotonin and also inhibits the mitogenic effect of serotonin on vascular smooth muscle cells." | 2.67 | Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty. A multicenter randomized double-blind placebo-controlled trial. ( Ball, SG; Decoster, O; Emanuelsson, H; Heyndrickx, GR; Klein, W; Liberman, H; Rutsch, W; Schroeder, E; Serruys, PW; Tijssen, JP, 1993) |
| "Accordingly, coronary thrombosis was induced in anesthetized, open-chest dogs by insertion of a copper coil into the left anterior descending coronary artery (LAD)." | 1.27 | Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis. ( Ashton, JH; Buja, LM; Glas-Greenwalt, P; Golino, P; McNatt, J; Willerson, JT, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Larisch, R | 1 |
| Klimke, A | 1 |
| Hamacher, K | 1 |
| Henning, U | 1 |
| Estalji, S | 1 |
| Hohlfeld, T | 1 |
| Vosberg, H | 1 |
| Tosch, M | 1 |
| Gaebel, W | 1 |
| Coenen, HH | 1 |
| Müller-Gärtner, HW | 1 |
| Serruys, PW | 1 |
| Klein, W | 2 |
| Tijssen, JP | 1 |
| Rutsch, W | 1 |
| Heyndrickx, GR | 1 |
| Emanuelsson, H | 1 |
| Ball, SG | 1 |
| Decoster, O | 1 |
| Schroeder, E | 1 |
| Liberman, H | 1 |
| Eber, B | 1 |
| Dusleag, J | 1 |
| Rotman, B | 1 |
| Költringer, P | 1 |
| Luha, O | 1 |
| Vanhoutte, PM | 1 |
| Brune, S | 1 |
| Tebbe, U | 1 |
| Schmidt, T | 1 |
| Benn, HP | 1 |
| Seiler, KU | 1 |
| Kreuzer, H | 1 |
| Golino, P | 1 |
| Ashton, JH | 1 |
| Glas-Greenwalt, P | 1 |
| McNatt, J | 1 |
| Buja, LM | 1 |
| Willerson, JT | 1 |
3 trials available for ketanserin and Recrudescence
| Article | Year |
|---|---|
Influence of synaptic serotonin level on [18F]altanserin binding to 5HT2 receptors in man.
Topics: Adult; Antidepressive Agents, Tricyclic; Brain; Clomipramine; Depressive Disorder, Major; Drug Inter | 2003 |
Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty. A multicenter randomized double-blind placebo-controlled trial.
Topics: Adult; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Double-Blind Method; | 1993 |
Ketanserin prevents early restenosis following percutaneous transluminal coronary angioplasty.
Topics: Adenosine Diphosphate; Adult; Aged; Angiography; Angioplasty, Balloon, Coronary; Coronary Disease; D | 1990 |
2 other studies available for ketanserin and Recrudescence
| Article | Year |
|---|---|
Prevention of an early re-occlusion after thrombolytic therapy of acute myocardial infarction by ketanserin.
Topics: Adult; Aged; Female; Humans; Ketanserin; Male; Middle Aged; Myocardial Infarction; Recombinant Prote | 1990 |
Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis.
Topics: Animals; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Coronary Circulation; Coronary Di | 1988 |